Potential swing trades:
Longs - None until August
Shorts - None until August
Potential day trades:
(From Briefing.com)
Gapping Down
PIXR -12% (lowers Q2 guidance, Thomas Weisel downgrade), RDWR -17% (guides Q2 significantly lower), IONA -11% (lowers Q2 guidance), ICAD -11% (Q2 guidance), LPMA -7.4% (guides below consensus for Q2).
Gapping Up
SHLD +2.6% (started with a Buy at Deutsche Bank; tgt $185), PANL +12% (announces fundamental breakthrough in blue phosphorescent OLEDs), NTMD +3.6% (announces launch of BiDil for treatment of heart failure), IIJI +2.6%, TASR +2% (files suit against USA Today), RHAT +1.8% (reports MayQ, CSFB upgrade), NVDA +1.1% (DigiTimes: delay of ATI R520 to boost Nvidia Q4 sales).... Under $3: CHRD +20% (JMP Sec upgrade), IPIX +13% (secures a $2.4 mln research contract), SPAB +10% (trades higher ahead of NASA's Deep Impact mission on July 4 to crash into a comet, SPAB provided pre-launch services).
Intraday Updates:
- 00:00
Mike,
Do you know of any forex blogs?
Thanks,
Steve
Why did NitroMed (NTMD) only increase 13% on news that it would begin sales of its drug BilDil by 7 July? Based on the market for Nitric Oxide drugs BilDil should bring sales of $220 million by 4Q 2005 and $550M by 3Q 2006. That would put NTMD's book value at $42/share. It is currently priced at $22/sh. Why is there such an unvaluation of this stock. Is it still undiscovered?
Sorry Steve, I don't